Mainboard · BSE and NSEListed

Sahajanand Medical technologies Limited IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Mon 16 Nov 2026, 12:11 pm IST · Source: Basis of allotment dated Thu 22 Oct 2026

Bid dates
Thu 15 Oct 2026 to Mon 19 Oct 2026
Listing date
Fri 23 Oct 2026
Issue price
₹344 per share

Listed on BSE and NSE on Fri 23 Oct 2026.

Listing price ₹368.05

Opening price on BSE on the listing day (BSE daily price file for Fri 23 Oct 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹344 per share
chittorgarh.com and groww.in, as of Mon 16 Nov 2026
Lot size
Not stated in the RHP
RHP dated Fri 9 Oct 2026
Lot amount at the upper band
Not stated in the RHP
RHP dated Fri 9 Oct 2026
Issue size at the upper band
₹475.48 crore
Computed from the issue price (chittorgarh.com and groww.in, as of Mon 16 Nov 2026)
Fresh issue
None
RHP dated Fri 9 Oct 2026, page 1
Offer for sale
1,38,22,116 shares (Amount not stated in the RHP)
RHP dated Fri 9 Oct 2026, page 1
Bid dates
Thu 15 Oct 2026 to Mon 19 Oct 2026
RHP dated Fri 9 Oct 2026, page 2
Listing date
Fri 23 Oct 2026
BSE daily price file for Fri 23 Oct 2026
Anchor lock-in ends
Set after bidding
RHP dated Fri 9 Oct 2026
Risk factors
81
RHP dated Fri 9 Oct 2026, page 71

Timeline (IST)

  1. OpensThu 15 Oct 2026, 10:00 am IST confirmedRHP dated Fri 9 Oct 2026, page 2
  2. ClosesMon 19 Oct 2026 confirmedRHP dated Fri 9 Oct 2026, page 2
  3. UPI mandate cut-offNot stated in the RHP RHP dated Fri 9 Oct 2026
  4. AllotmentWed 21 Oct 2026 by T+3 schedule
  5. Refund and unblockThu 22 Oct 2026 by T+3 schedule
  6. Shares to dematThu 22 Oct 2026 by T+3 schedule
  7. ListingFri 23 Oct 2026 confirmedBSE daily price file for Fri 23 Oct 2026

Company and promoters

As described in the RHP

We are a R&D-driven company engaged in the development of Class III and Class C/D medical devices, with an emphasis on Vascular Intervention (“VI”) and Structural Heart (“SH”).

RHP dated Fri 9 Oct 2026, page 255

Promoters

  • 4 individual promoters

RHP dated Fri 9 Oct 2026, page 335

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group40.82%Not stated in the RHP

RHP dated Fri 9 Oct 2026, page 116

Financials (restated)

ItemFor the three months period ended June 30, 2026For the year ended March 31, 2026For the year ended March 31, 2025For the year ended March 31, 2024
Revenue from operations₹351.67 crore₹1,210.50 crore₹1,024.88 crore₹901.60 crore
Profit after tax₹15.09 crore₹69.08 crore₹25.15 crore-₹7.35 crore
Net worth₹709.37 crore₹695.46 crore₹565.73 crore₹540.09 crore
Total borrowingsNot stated in the RHPNot stated in the RHPNot stated in the RHPNot stated in the RHP

RHP dated Fri 9 Oct 2026, page 76

Who is selling in the offer for sale

Selling shareholderTypeShares offeredAmount at the upper band
Shree Hari TrustOther27,00,000Not stated in the RHP
Individual shareholderIndividual20,00,000Not stated in the RHP
Samara Capital Markets Holding LimitedCompany64,79,063Not stated in the RHP
Kotak Pre-IPO Opportunities FundFund13,07,875Not stated in the RHP
NHPEA Sparkle Holding B.V.Company13,35,178Not stated in the RHP
Total offer for saleNot stated in the RHP

RHP dated Fri 9 Oct 2026, page 1

Risk factors

81 total
  1. The company is subject to extensive regulation, and adverse action by an authority could hurt its ability to sell products (RHP page 25)
  2. Manufacturing facilities face quality control, infrastructure and machinery risks that could raise costs or interrupt operations (RHP page 27)
  3. Delays or failure in obtaining or renewing permits and licences for the manufacturing facilities could affect the business (RHP page 30)
  4. Investors may be subject to Indian taxes on gains from selling the shares and on dividends (RHP page 70)
  5. Foreign investment restrictions under Indian law may limit foreign investors and affect the share price (RHP page 71)

All 81 risk factors, RHP pages 25 to 71

Offer document

Allotment and bids

Registrar to the issue: MUFG Intime India Private Limited (Formerly Link Intime India Private Limited).

Allotment status was expected on the registrar's site from Wed 21 Oct 2026 and is not yet confirmed. Pick "Sahajanand Medical technologies Limited" from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Retail Individual Bidders47,50,2411,47,27,3713.10×
Non-Institutional Bidders – More than ₹ 26,78,60676,51,37711.28×
Non-Institutional Bidders – More than 10 lakhs13,57,2122,22,56,41316.40×
Employee2,50,00047,3430.19×
Qualified Institutional Bidders27,14,4239,41,28,37634.68×
Anchor Investors40,71,63440,71,6701.0×
Total97,50,48213,88,10,88014.24×

Total: Excluding anchor investors

Basis of allotment dated Thu 22 Oct 2026, page 2

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts